Financials
Income statement
Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
---|---|---|---|---|
Total reported revenue | 22.2T | 17.6T | 19.8T | 17.6T |
Cost of revenue | 10.2T | 7.5T | 9.4T | 8.4T |
Gross profit | 12.0T | 10.1T | 10.4T | 9.2T |
Operating expense | ||||
Research & development | — | 1.5T | 1.3T | 1.1T |
Selling general and admin | 2.8T | 434.1B | 496.5B | 430.4B |
Other operating expenses | — | 28.9B | 28.1B | 27.2B |
Operating income | 12.0T | 7.4T | 8.1T | 7.0T |
Non operating interest income | ||||
Income | — | 106.0B | 98.4B | 81.8B |
Expense | — | 257.5B | 268.5B | 315.0B |
Other income expense | — | — | — | — |
Pretax income | 8.7T | 9.3T | 9.6T | 6.9T |
Tax provision | 1.7T | 1.2T | 1.6T | 1.1T |
Net income | 7.0T | 8.1T | 8.0T | 5.8T |
Basic EPS | 10.1K | 11.8K | — | 8.3K |
Diluted EPS | 10.1K | 11.4K | — | 7.9K |
Basic average shares | — | 689.6M | — | 689.0M |
Diluted average shares | — | 710.8M | — | 709.9M |
EBITDA | 12.0T | 11.0T | 12.1T | 10.3T |
Net income from continuing op. | — | 8.1T | 8.0T | 5.8T |
Minority interests | 1.0B | -1.1B | -6.0B | -4.7B |
Preferred stock dividends | — | — | — | — |